Trimetazidine Reduces Endogenous Free Fatty Acid Oxidation and Improves Myocardial Efficiency in Obese Humans-Reference-Cited by-同舟云学术

Trimetazidine Reduces Endogenous Free Fatty Acid Oxidation and Improves Myocardial Efficiency in Obese Humans

Published:2011-07-31 Issue:6 Volume:30 Page:333-341
ISSN:1755-5914
Container-title:Cardiovascular Therapeutics
language:en
Short-container-title:Cardiovasc Ther

Author:

Bucci Marco,Borra Ronald,Någren Kjell,Pärkkä Jussi P.,Del Ry Silvia,Maggio Romina,Tuunanen Helena,Viljanen Tapio,Cabiati Manuela,Rigazio Sara,Taittonen Markku,Pagotto Uberto,Parkkola Riitta,Opie Lionel H.,Nuutila Pirjo,Knuuti Juhani,Iozzo Patricia

Publisher

Wiley

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1755-5922.2011.00275.x/fullpdf

Reference47 articles.

1. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase;Kantor;Circ Res,2000

2. Beneficial effects of trimetazidine in ex vivo working ischemic hearts are due to a stimulation of glucose oxidation secondary to inhibition of long-chain 3-ketoacyl coenzyme a thiolase;Lopaschuk;Circ Res,2003

3. Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy;Tuunanen;Circulation,2008

4. Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham Heart Study;Hubert;Circulation,1983

5. Obesity and the risk of heart failure;Kenchaiah;N Engl J Med,2002

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human cardiac metabolism;Cell Metabolism;2024-07

2. Modulating Cardiac Energetics in Cardio-Metabolic Syndromes: A mechanistic, hyperpolarized MR Trial of Ninerafaxstat Treatment;2024-04-25

3. Trimetazidine in heart failure with preserved ejection fraction: a randomized controlled cross‐over trial;ESC Heart Failure;2023-08-02

4. Myocardial lipids—techniques and applications of proton magnetic resonance spectroscopy of the human heart;Visceral and Ectopic Fat;2023

5. Myocardial Energy Metabolism in Non-ischemic Cardiomyopathy;Frontiers in Physiology;2020-09-16